Scinai Immunotherapeutics Ltd. (SCNI)
1.72
+0.02
(+1.18%)
USD |
NASDAQ |
Sep 09, 16:00
1.72
0.00 (0.00%)
After-Hours: 17:28
Scinai Immunotherapeutics Price to Book Value : 0.1606 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.1587 |
| September 04, 2026 | 0.1737 |
| September 03, 2026 | 0.1821 |
| September 02, 2026 | 0.2185 |
| September 01, 2026 | 0.2297 |
| August 31, 2026 | 0.2334 |
| August 28, 2026 | 0.2343 |
| August 27, 2026 | 0.2502 |
| August 26, 2026 | 0.268 |
| August 25, 2026 | 0.2689 |
| August 24, 2026 | 0.2922 |
| August 21, 2026 | 0.3006 |
| August 20, 2026 | 0.2745 |
| August 19, 2026 | 0.2558 |
| August 18, 2026 | 0.2199 |
| August 17, 2026 | 0.2131 |
| August 14, 2026 | 0.2264 |
| August 13, 2026 | 0.2241 |
| August 12, 2026 | 0.2306 |
| August 11, 2026 | 0.2203 |
| August 10, 2026 | 0.2346 |
| August 07, 2026 | 0.229 |
| August 06, 2026 | 0.2416 |
| August 05, 2026 | 0.2334 |
| August 04, 2026 | 0.2336 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.2549 |
| July 31, 2026 | 0.2549 |
| July 30, 2026 | 0.2577 |
| July 29, 2026 | 0.249 |
| July 28, 2026 | 0.2465 |
| July 27, 2026 | 0.2304 |
| July 24, 2026 | 0.2147 |
| July 23, 2026 | 0.2307 |
| July 22, 2026 | 0.2364 |
| July 21, 2026 | 0.2293 |
| July 20, 2026 | 0.2288 |
| July 17, 2026 | 0.2332 |
| July 16, 2026 | 0.2371 |
| July 15, 2026 | 0.2456 |
| July 14, 2026 | 0.2253 |
| July 13, 2026 | 0.225 |
| July 10, 2026 | 0.2341 |
| July 09, 2026 | 0.2409 |
| July 08, 2026 | 0.2521 |
| July 07, 2026 | 0.2408 |
| July 06, 2026 | 0.251 |
| July 02, 2026 | 0.2525 |
| July 01, 2026 | 0.254 |
| June 30, 2026 | 0.2358 |
| June 29, 2026 | 0.0155 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Compugen Ltd. | 2.647 |
| Pluri, Inc. | -- |
| Evogene Ltd. | -- |
| CollPlant Biotechnologies Ltd. | 9.889 |
| Regentis Biomaterials Ltd. | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.1871 |
| Price | 1.72 |
| Earnings Yield | -25.73K% |
| Market Cap | 0.9804M |